ESC 365 - Inhibition of fractalkine signalling in patients with acute myocardial infarction

Back

ESC Premium Access

Inhibition of fractalkine signalling in patients with acute myocardial infarction - First results from the FRACTAL trial

Session: Therapeutic targets for myocardial infarction

Topic: Leukocytes, Inflammation, Immunity

Speaker: Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Professor Ioakim Spyridopoulos

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)

1 presentation

1 follower

4 more presentations in this session

From bench to bedside and back to bench: investigating the role of platelet heterogeneity in coronary artery disease

Speaker: Doctor D. Bongiovanni (Augsburg, DE)

Downregulation of CPEB3 exacerbates cardiac injury by inhibiting cardiomyocyte adaptive metabolic reprogramming after myocardial infarction

Speaker: Doctor Z. Tao (Nanjing, CN)

Lipin1 prevents ischemic heart disease by regulating lipid homeostasis

Speaker: Doctor J. Guo (Tokyo, JP)

Oxct1 regulates cardiomyocyte PANoptosis in acute myocardial infarction via succinylating Tfam

Speaker: Miss X. Li (Nanjing, CN)

Access the full session

Therapeutic targets for myocardial infarction

Speakers: Professor I. Spyridopoulos, Doctor D. Bongiovanni, Doctor Z. Tao, Doctor J. Guo, Miss X. Li

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources